Lataa...
Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy
The vast majority (85%) of pancreatic ductal adenocarcinomas (PDACs) are discovered at too of a late stage to allow curative surgery. In addition, PDAC is highly resistant to conventional methods of chemotherapy and radiotherapy, which only offer a marginal clinical benefit. Consequently, the progno...
Tallennettuna:
| Julkaisussa: | Hum Gene Ther |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mary Ann Liebert, Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779299/ https://ncbi.nlm.nih.gov/pubmed/26731312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2015.151 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|